Molekulardiagnostik

PHOENIXDX® SARS-COV-2 MULTIPLEX IVD ist ein in-vitro Diagnostik Test zum Nachweis viraler 2019- Novel Coronavirus (SARS-CoV-2) RNA aus Proben aus dem Respirationstrakt von Patienten, die den klinischen und/oder epidemiologischen Kriterien entsprechen.

PHOENIXDX® COFLUENZA 4-PLEX IVD is a real-time RT-PCR-based diagnostic test for the in vitro qualitative detection of Influenza A, Influenza B and SARS-CoV-2 in respiratory specimens and sera.

PHOENIXDX® SARS-COV-2 MUTANT SCREEN [N501Y] is a real-time RT-PCR-based diagnostic test for the in vitro discrimination between wildtype SARS-CoV-2 and N501Y mutant SARS-CoV-2 in respiratory specimens and sera.

PHOENIXDX® SARS-COV-2 IVD is a real-time RT-PCR-based diagnostic test for the in vitro qualitative detection of 2019-Novel Coronavirus (SARS-CoV-2) in respiratory specimens and sera from patients who meet COVID-19 clinical and/or epidemiological criteria.

kit for the detection of deltaF508 mutation in CFTR gene by real-time PCR technology using TaqMan® probes technology.

Genvinset® HLA DQA1*05 is a semi-automated in vitro diagnostic kit for the qualitative detection of the HLA-DQA1*05 allele in genomic DNA extracted from whole blood, associated with the immunogenicity of anti-TNF drugs, by Real-Time PCR using TaqMan® probes technology.

Kit for detecting HLA-DRB1*03, DRB1*04, DQB1*02:01 and DQB1*03:02 alleles by Real Time PCR using TaqMan® probes technology.

Kit for detecting the HLA-C*06 alleles by Real Time PCR using TaqMan® probes technology.

Kit for the determination of the CAG and CTA/CTG triplet repeats number (SCAs 1, 2, 3, 6, 7 and SCA 8, respectively) by fluorescent fragment analysis.